TABLE 3.
List of exomiRs associated with tumour recurrence.
| Centralize the miRNAs ID | Pattern of expression | Tumour type | References |
|---|---|---|---|
| ExomiR-106a-5p | Increased | Gastric cancer metastasis | Yuan et al. (2016) |
| ExomiR-4772-3p | Increased | Recurrence in stage II and III colon cancer | Liu et al. (2016a) |
| ExomiR-19a | Increased | Recurrence in Colorectal cancer | Matsumura et al. (2015) |
| ExomiR-3653 | Increased | Pancreatic neuroendocrine tumour | Gill et al. (2019) |
| ExomiR-1307-5p and exomiR-103 | Increased | Hepatocellular carcinoma | Fang et al. (2018a), Eun et al. (2020) |
| ExomiR-1247-3p | Increased | Liver cancer | Fang et al. (2018b) |
| ExomiR-718 | Decreased | Recurrence in hepatocellular carcinoma | Sugimachi et al. (2015) |
| ExomiR-21 | Increased | Esophageal squamous cell cancer | Tanaka et al. (2013) |
| ExomiR-497-5p | Decreased | Non-small cell lung cancer | Huang et al. (2019) |
| ExomiR-141, exomiR-146b-3p and exomiR-194 | Increased | Recurrence in prostate cancer | Selth et al. (2013) |
| ExomiR-275 | Increased | Recurrence in bone marrow In prostate cancer |
Jiang et al. (2022) |
| ExomiR-148a-3p | Decreased | Lymph node metastasis in ovarian cancer | Gong et al. (2016) |
| ExomiR-21 | Increased | Recurrence in glioma | Shi et al. (2015) |
| ExomiR‐375 | Increased | Bone marrow metastases in patients with neuroblastoma | Colletti et al. (2020) |